Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies.

about

Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies.

Item

http://www.wikidata.org/entity/Q40267179

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Do antiepileptic drugs increas ...... of placebo-controlled studies.

@en

type

Item

label

Do antiepileptic drugs increas ...... of placebo-controlled studies.

@en

prefLabel

Do antiepileptic drugs increas ...... of placebo-controlled studies.

@en

P1476

Do antiepileptic drugs increas ...... of placebo-controlled studies.

@en

P2093

Fabio Giovannelli

http://www.w3.org/2001/XMLSchema#string

Filippo Sean Giorgi

http://www.w3.org/2001/XMLSchema#string

Francesco Mandò Tacconi

http://www.w3.org/2001/XMLSchema#string

Gaetano Zaccara

http://www.w3.org/2001/XMLSchema#string

Sara Gasparini

http://www.w3.org/2001/XMLSchema#string

Valentina Franco

http://www.w3.org/2001/XMLSchema#string

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

Augmented lung inflammation protects against influenza A pneumonia.

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus.

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Safety profile of levetiracetam.

P304

1873-1879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/BCP.13296

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28370224

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5555858

http://www.w3.org/2001/XMLSchema#string